Try our Advanced Search for more refined results
Mergers & Acquisitions
Mergers & Acquisitions Law360 provides breaking news and analysis on high-impact mergers and acquisitions and the attorneys involved. Coverage includes major deals, related litigation and enforcement actions, and policy developments that affect corporate dealmaking.
Sign up for a 7-day FREE trial today!
Latest News in Mergers & Acquisitions
-
November 17, 2025
Chancery Mulls Receiver For Foundering Gaming Chat Co.
Saying the court stands at "the outer boundaries" of precedent, a Delaware vice chancellor on Monday declined for now to appoint a receiver for voided online gaming chat venture TeamSpeak and ordered targeted discovery regarding the standing of a stockholder who sued the company's directors and others for alleged breaches of fiduciary duty.
-
November 17, 2025
UConn Health Poised To Buy Hospital In $35M Ch. 11 Deal
Bankrupt for-profit hospital operator Prospect Medical Holdings Inc. on Monday sought approval for the $35 million sale of Waterbury Hospital in Connecticut to two UConn Health units under a stalking horse bid package filed in early November.
-
November 17, 2025
DOJ Defends HPE Merger Deal As 'Prudent Compromise'
The Justice Department told a California federal judge to pay no heed to the "politicians and advocacy groups" opposing the controversial settlement clearing Hewlett Packard Enterprise's $14 billion purchase of Juniper Networks, arguing their concerns about improper lobbying influence are outside the scope of the court's review.
-
November 17, 2025
TerraForm Stockholders Settle Suit Over Brookfield Merger
Brookfield Asset Management Inc. and TerraForm Power Inc. stockholders reported a tentative, undisclosed deal on Monday to end their nearly four-year Delaware Chancery Court battle over Brookfield's alleged "exploitation" of TerraForm's minority stockholders in a deal dating to 2020.
-
November 17, 2025
Cravath, Goodwin Advise On J&J's $3B Cancer Drug Play
Cravath-advised Johnson & Johnson said Monday it has agreed to pay $3.05 billion in cash for Goodwin-led Halda Therapeutics, a biotech developing a clinical-stage therapy for prostate cancer.
Areas of Coverage
- TRANSACTIONS
- Mergers and acquisitions valued at $100MM or more
- Company spinoffs and splitups
- Transactions involving stakes of $100MM or more
- Hostile takeovers and leveraged buyouts
- Poison pill implementation
- Bankruptcy selloffs
- AGENCIES
- Financial Industry Regulatory Authority
- Federal Trade Commission
- U.S. Department of Justice
- POLICY & REGULATION
- Dodd-Frank Act
- International banking legislation and regulation
- ENFORCEMENT
- Merger reviews
- Second requests
- Challenges and divestitures
- LITIGATION
- Antitrust suits
- Bankruptcy proceedings
- Shareholder disputes
- Corporate governance fights
- Proxy battles and hostile takeover suits
- Poison pill challenges
- PROFILES
- Personnel moves
- Profiles of mergers and acquisitions practices
Readership
- Mergers and acquisitions lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals